ATYR
Atyr Pharma, Inc.
Clinical-stage biotherapeutics company focused on tRNA synthetase biology
CUSIP: 002120202HealthcareUS1 holder
Total Value
$956.0K
Total Shares
229.3K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$956.0K229.3K sharesUnchanged